Navigation Links
Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
Date:4/26/2009

study. Relapse rates between these two arms also were not significantly different (32.7 percent (16/49) vs. 47.1 percent (32/68), respectively) and adverse events were similar among treatment groups (secondary endpoints). Early discontinuation rates were higher in the 72-week arm compared to the 48-week arm (23.3 percent (17/73) vs. 9.3 percent (8/86), respectively).

Reduced Dose and Duration of Peginterferon Alfa-2b + Weight-Based Ribavirin in European and Asian Genotype 2 and 3 Chronic Hepatitis C Patients (REDD 2/3 Trial)(4)

Shorter duration treatment of patients chronically infected with HCV genotype 2 or 3 (G2/3) with peginterferon and ribavirin has been largely unsuccessful compared with standard-duration treatment (24 weeks). The implications of a reduced peginterferon dose in G2/3 patients were unknown. The primary objective of the REDD 2/3 study was to evaluate the effect of reduced treatment duration or a reduced PEGINTRON dose on SVR and relapse rates among treatment-naive G2/3 patients in an international, multicenter, non-inferiority study. The study began as a real-world, investigator-initiated study conducted in Germany and then the patient population was expanded to include centers in Europe and Asia-Pacific. In total, 682 patients were treated. Of these, 80.2 percent were G3 and 53.1 percent had high baseline viral load (greater than or equal to 600,000 IU/mL), both negative factors for achieving SVR.

Eligible patients were randomized to one of three arms: (A) PEGINTRON (1.5 mcg/kg/wk) for 24 weeks (approved dose), (B) PEGINTRON (1.0 mcg/kg/wk) for 24 weeks (low dose) or (C) PEGINTRON (1.5 mcg/kg/wk) for 16 weeks (short duration), each in combination with weight-based REBETOL (800-1200 mg/day). Co-primary end points were non-inferiority between arms A and B and A and C. SVR rates overall were (A) 66.5 percent (153/230), (B) 64.3 percent (144/224) and (C) 56.6 percent (129/228). Neither
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  According to the American ... children spend on digital devices. An AOA survey reports ... 10 and 17 estimate they use an electronic device ... separate AOA survey of parents revealed that only 40 ... device for that same amount of time. Eye doctors ...
(Date:7/22/2014)... , July 22, 2014  Vernalis plc (LSE: VER) and ... proof-of-concept (POC) for CCP-08, the third programme to ... cold collaboration. Under this collaboration, POC requires the ... human pilot comparative study against an immediate release ... Vernalis will make a milestone payment to Tris. ...
(Date:7/22/2014)... PORT WASHINGTON, New York , ... Neue Partnerschaft für umfassenden ... gefährlichen Medikamenteneinwirkungen in Österreich    ... führender Anbieter von geschlossenen Transfersystemen (Closed System ... Medikus , einen Vertriebshändler und ...
Breaking Medicine Technology:Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 2Third Product in Vernalis' Cough Cold Pipeline (CCP-08) Achieves Proof-of-Concept 3Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2
... Jan. 6, 2011 Lexicon Pharmaceuticals, Inc. ... on discovering breakthrough treatments for human disease, announced data ... of a solid oral dose formulation for LX4211, a ... and SGLT2). Results from the study demonstrated ...
... CHAPEL HILL, N.C., Jan. 5, 2011 The ... pipeline is pushing strategy and development executives to ... opportunity lies in combination therapies with branded products ... dose combination (FDC) products can extend a therapeutic ...
Cached Medicine Technology:Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients 2Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients 3Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients 4Report Highlights Successful Strategies for Bringing FDC Products to Market 2
(Date:7/22/2014)... 2014 The Pennsylvania judge overseeing ... in the Philadelphia Court of Common Pleas ... in cases alleging the medication caused plaintiffs to ... reports. In an Order dated July 18, 2014, ... to certify the matter for an immediate appeal ...
(Date:7/22/2014)... -- One of the largest studies ever conducted into ... 83 new sites on chromosomes that harbor inherited genes ... international team of researchers, now bring the total number ... 108. Although these schizophrenia-associated genes aren,t specific ... who will or will not develop the illness, researchers ...
(Date:7/22/2014)... 2014 CarePoint Health is pleased to announce ... President of the medical staff at Bayonne Medical Center. The ... President, as voted on by the physicians on staff. The ... in relation to the administration at Bayonne Medical Center. Dr. ... to work to make the Medical Center the best it ...
(Date:7/22/2014)... from the Edusei Foundation was greatly appreciated by the staff ... engineering, such assistance tends to etch good memories of family ... a sense of family to them, which the Edusei Foundation ... donated various amounts of; milk, soap, frytol, sugar, malt milk, ... Ghana established the Kumasi Children’s Home in 1965 to provide ...
(Date:7/22/2014)... July 22, 2014 Hospitals ... survey was conducted by Hospitals & Health ... Association, AT&T, CareTech Solutions, The College of ... Most Wired list recognizes hospitals for successful ... evaluates hospitals in four focus areas: business ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 4Health News:Gene Discoveries Could Shed New Light on Schizophrenia 2Health News:Dr. Howard Levine Elected President of the Medical Staff at Bayonne Medical Center 2Health News:Edusei Foundation Donates Food and Needed Items to Kumasi Children’s Home in Ashanti Region of Ghana 2Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 2Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 3Health News:Healthline Systems’ Clients Honored Among Most Wired for 2014 4
... fevers (FHFs) such as those caused by the Ebola ... have the support and trust of local communities, according ... of the Journal of Infectious Diseases as part of ... exist of the experiences of outbreak control teams, and ...
... growing demand for reconciling medications across the healthcare continuum ... ... of CPOE, SAN BRUNO, Calif., Oct. 29 First ... Med Knowledge Base(TM), a computerized physician order entry,(CPOE)-ready drug database ...
... Company Expands Support to 75 Percent of Military ... CACI International,Inc (NYSE: CAI ) announced today ... task order contract to support the Military Health ... the award, CACI will,supply information assurance solutions to ...
... Group ... Chicago, DALLAS, Oct. 29 Affiliated Computer Services,Inc. ... meet the changing healthcare needs of retirees, including,millions of ... Informed Health Navigator is an innovative product that analyzes,retirees, ...
... detection and treatment recommendations, , , MONDAY, Oct. 29 ... it easier for pediatricians to spot and begin ... the American Academy of Pediatrics has released two ... these conditions. , "Pediatricians are the front line" ...
... Management Diary Provides Easy Way to Record, Track and Share Health ... ... Oct. 29 ReliefInsite,( http://www.reliefinsite.com ) today unveiled a new release ... way,for companies and developers to integrate with the Facebook website. With,more ...
Cached Medicine News:Health News:Agencies must win trust of locals to contain Marburg and Ebola outbreaks 2Health News:Agencies must win trust of locals to contain Marburg and Ebola outbreaks 3Health News:Agencies must win trust of locals to contain Marburg and Ebola outbreaks 4Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 2Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 3Health News:HealthTek Software Solutions Licenses First DataBank's OrderView Med Knowledge Base(TM) to Streamline Medication Selection, Management and Reconciliation 4Health News:CACI Awarded $64 Million Contract to Provide Information Assurance Support for Military Health System 2Health News:CACI Awarded $64 Million Contract to Provide Information Assurance Support for Military Health System 3Health News:CACI Awarded $64 Million Contract to Provide Information Assurance Support for Military Health System 4Health News:ACS Launches Product to Help Employers Navigate Health Choices For Employees Entering Retirement Years 2Health News:Pediatricians' Group Issues New Autism Guidelines 2Health News:Pediatricians' Group Issues New Autism Guidelines 3Health News:ReliefInsite Launches First Patient Health Record on Facebook(R) Platform 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: